Emerging therapies in the pharmacological treatment of Parkinson's disease.
about
Multifunctional receptor-directed drugs for disorders of the central nervous systemManaging the critical problems of advanced Parkinson's disease.Continuous dopaminergic stimulation and novel formulations of dopamine agonists.Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice.
P2860
Emerging therapies in the pharmacological treatment of Parkinson's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@ast
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@en
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@nl
type
label
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@ast
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@en
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@nl
prefLabel
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@ast
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@en
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@nl
P1433
P1476
Emerging therapies in the pharmacological treatment of Parkinson's disease.
@en
P2093
Miri Nussbaum
P304
P356
10.2165/00003495-200262050-00005
P577
2002-01-01T00:00:00Z
P5875
P6179
1033229440